about
Breast cancer stroma frequently recruits fetal derived cells during pregnancyIdentification and functional analysis of a new WNT4 gene mutation among 28 adolescent girls with primary amenorrhea and müllerian duct abnormalities: a French collaborative studyTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsMultigene assays and molecular markers in breast cancer: systematic review of health economic analysesThe MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value?Prospective comparison of clinical and genomic multivariate predictors of response to neoadjuvant chemotherapy in breast cancer.A single-institution study of 117 pregnancy-associated breast cancers (PABC): Presentation, imaging, clinicopathological data and outcome.Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responsesNeoadjuvant chemotherapy or primary surgery for stage III/IV ovarian cancer: contribution of diagnostic laparoscopyHistological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinomaDoes the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?Ultrastaging of lymph node in uterine cancersMicrotubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancerPolarity gene alterations in pure invasive micropapillary carcinomas of the breastThe molecular subtype classification is a determinant of sentinel node positivity in early breast carcinomaGene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer.A double blind randomized trial of wound infiltration with ropivacaine after breast cancer surgery with axillary nodes dissection.Skin lesions after prophylactic mastectomy and immediate reconstructionCan the centrosome be a marker for DNA ploidy in breast cancer?Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival.Results of conservative management of epithelial malignant and borderline ovarian tumours.Non-invasive tools for the diagnosis of potentially life-threatening gynaecological emergencies: a systematic review.The patient-breast cancer care pathway: how could it be optimized?Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer.Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based modelsImpact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World PopulationFrom prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancerBeyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy.Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine administered according to 2- and 3-dose schedules in girls aged 9-14 years: Results to month 12 from a randomized trial.The role of aromatase inhibitors in the adjuvant treatment of breast carcinoma: the M. D. Anderson Cancer Center evidence-based approach.Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay.Prospective Clinical Utility Study of the Use of the 21-Gene Assay in Adjuvant Clinical Decision Making in Women With Estrogen Receptor-Positive Early Invasive Breast Cancer: Results From the SWITCH StudyLow Concordance between Gene Expression Signatures in ER Positive HER2 Negative Breast Carcinoma Could Impair Their Clinical Application.Gene expression profiling of primary breast cancer.Update on the role of laparoscopy in the treatment of gynaecological malignancy.Evaluation of the Effects of Pasireotide LAR Administration on Lymphocele Prevention after Axillary Node Dissection for Breast Cancer: Results of a Randomized Non-Comparative Phase 2 Study.Individualized chemotherapy treatment for breast cancer: is it necessary? Is it feasible?
P50
Q21195222-A9675E8C-7646-439C-8C37-10E01650BBE2Q24305984-CC1A2896-1C80-433C-A7A4-FE74B99E8FF6Q26776394-BC6979AD-177F-41B2-8A03-BE8AFB27E64CQ26825362-ACA63981-352E-4140-9750-F6E2C4E2F9CCQ30313224-FB93E6FD-4637-4419-9F58-6FD8DB2AB677Q30433483-52BB8701-46F1-487D-8DB3-045F3A32AAA0Q30746540-78D5C6D8-5DEF-467A-ADB3-549FFE3A4C30Q33325635-3E85E876-021F-456A-9F42-C0A23CC3695EQ33461909-923D2F13-0C9B-41AA-AF55-F5BACDFEFF88Q33555247-6D826D4D-3B65-41A9-99DA-B4DD44485786Q33678314-8F0CD098-50D3-4220-8E18-B130D9B382FCQ33689902-1E3CC4F0-4B5F-4BA0-BFCD-A8D37F094417Q33852049-E6CF44CF-6EFD-4FD0-B353-FC272918A2CEQ33892823-E9E916C2-E1E7-42FC-81E5-A945F6C9E794Q33927159-813975EC-7C54-4984-B339-C16AB4BB8F3CQ33989876-C833EC11-8D3E-497C-8FD0-D2F1AE9EF1E5Q34083052-EFA12D48-CAA6-4671-932C-7ED8B7863902Q34239191-C1045E6A-9BF6-4923-8903-E0EF0830604BQ34334059-14DDCC17-4507-43FA-B7C2-3978261BEE9AQ34443092-11367A66-7DC0-41B6-94A9-166653F83D5AQ35021646-78435DA2-647B-405A-97E5-661775243A91Q35076602-0588F585-891C-4B57-A4FB-6FE6C67AFE2AQ35089397-A78E83DA-B96E-4BFC-B91A-A6117FD0C1FEQ35129246-14F03A86-601F-4262-885B-B8098F015662Q35130514-99766A1B-6667-4183-8FF4-0F65A101EE27Q35604139-9A7F2116-456A-44BB-9DBD-6FCD7237A06EQ35653892-164A1644-5A5E-4EB3-A950-F6DF43257BD6Q35678667-9604E86B-A5FA-4432-AE2A-FB8A9F44D8CFQ35716564-57211036-750E-4E67-B192-FE69C886334FQ35831356-4C36469A-A9FB-4474-A045-DB4D67720BA5Q35873283-A21E8D16-2047-4A6A-BEC2-67E16C4945A2Q35886910-FB98E979-1523-4EE4-AAC2-9CFA155F1849Q35892321-D2B21F7B-AA1F-4A32-A7D2-5B11CD29596AQ35909719-32E31151-D7F4-4E54-8F27-627C26F70130Q35915708-18A8C562-F10E-457B-9950-A4093794C444Q35928728-05A76E26-9B95-4B3F-B1F9-646BF3A20D89Q35989734-31F40AB7-700D-4DAD-B271-5BE14B0185D3Q36042193-18B24940-1A20-440B-BB40-8EAFD1647B53Q36046389-B9F89D79-3F2E-4EDE-BCCD-065C1C881C3EQ36080033-BE4BD6BE-5575-4ADD-8CDC-C9DF38C2E22D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Roman Rouzier
@ast
Roman Rouzier
@en
Roman Rouzier
@es
Roman Rouzier
@nl
Roman Rouzier
@sl
type
label
Roman Rouzier
@ast
Roman Rouzier
@en
Roman Rouzier
@es
Roman Rouzier
@nl
Roman Rouzier
@sl
prefLabel
Roman Rouzier
@ast
Roman Rouzier
@en
Roman Rouzier
@es
Roman Rouzier
@nl
Roman Rouzier
@sl
P214
P106
P21
P213
0000 0001 2304 9825
P214
P31
P496
0000-0002-8167-6808
P735
P7859
viaf-172719247